DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,303,015 | -1.5% | 81,834 | -4.7% | 1.04% | +7.4% |
Q2 2023 | $20,606,400 | +601.1% | 85,860 | +636.3% | 0.97% | +568.3% |
Q1 2023 | $2,939,038 | -86.2% | 11,661 | -85.4% | 0.14% | -83.2% |
Q4 2022 | $21,223,780 | +9.1% | 79,963 | +6.2% | 0.86% | -14.6% |
Q3 2022 | $19,454,000 | -9.9% | 75,318 | -11.6% | 1.01% | -6.3% |
Q2 2022 | $21,590,000 | +15.7% | 85,161 | +33.8% | 1.08% | +50.4% |
Q1 2022 | $18,663,000 | +1447.5% | 63,625 | +1035.8% | 0.72% | +908.5% |
Q3 2020 | $1,206,000 | +55.6% | 5,602 | 0.0% | 0.07% | +14.5% |
Q1 2020 | $775,000 | -24.6% | 5,602 | -16.4% | 0.06% | -17.3% |
Q4 2019 | $1,028,000 | +6.2% | 6,701 | 0.0% | 0.08% | -5.1% |
Q3 2019 | $968,000 | +1.0% | 6,701 | 0.0% | 0.08% | -2.5% |
Q2 2019 | $958,000 | +12.2% | 6,701 | +3.6% | 0.08% | -4.7% |
Q1 2019 | $854,000 | +28.0% | 6,467 | 0.0% | 0.08% | +44.1% |
Q4 2018 | $667,000 | -5.1% | 6,467 | 0.0% | 0.06% | +20.4% |
Q3 2018 | $703,000 | +10.2% | 6,467 | 0.0% | 0.05% | +2.1% |
Q2 2018 | $638,000 | +0.8% | 6,467 | 0.0% | 0.05% | +11.6% |
Q1 2018 | $633,000 | -6.1% | 6,467 | -11.0% | 0.04% | +2.4% |
Q4 2017 | $674,000 | -1.2% | 7,263 | -8.6% | 0.04% | +7.7% |
Q3 2017 | $682,000 | +1.6% | 7,949 | 0.0% | 0.04% | +2.6% |
Q2 2017 | $671,000 | -1.3% | 7,949 | 0.0% | 0.04% | 0.0% |
Q1 2017 | $680,000 | -2.7% | 7,949 | -11.5% | 0.04% | -85.0% |
Q4 2016 | $699,000 | -0.7% | 8,979 | 0.0% | 0.25% | +5.4% |
Q3 2016 | $704,000 | -22.4% | 8,979 | 0.0% | 0.24% | +410.6% |
Q2 2016 | $907,000 | – | 8,979 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |